No Data
No Data
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street analyst Frank Takkinen maintains $IRadimed(IRMD.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 0.0% and a total
Express News | IRadimed Corp: Common Stock Will Uplist and Commence Trading on Nasdaq Global Market, Effective June 14, 2024
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION ("Iradimed") (NASDAQ:IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its
Have Insiders Sold IRADIMED Shares Recently?
We note that the IRADIMED CORPORATION (NASDAQ:IRMD) Independent Director, Monty Allen, recently sold US$84k worth of stock for US$43.37 per share. However we note that the sale only shrunk their ho
IRadimed(IRMD.US) Director Sells US$84,432.43 in Common Stock
$IRadimed(IRMD.US)$ Director ALLEN MONTY K sold 1,947 shares of common stock on Jun 3, 2024 at an average price of $43.3654 for a total value of $84,432.43.Source: Announcement What is statement of ch
IRADIMED (NASDAQ:IRMD) Is Achieving High Returns On Its Capital
No Data